Assessment of severity and frequency of self-reported hypoglycemia on quality of life in patients with type 2 diabetes treated with oral antihyperglycemic agents: A survey study
Open Access
- 21 July 2011
- journal article
- Published by Springer Nature in BMC Research Notes
- Vol. 4 (1) , 251
Abstract
Some oral antihyperglycemic agents may increase risk of hypoglycemia and thereby reduce patient quality of life. Our objective was to assess the impact of the severity and frequency of self-reported hypoglycemia on health-related quality of life (HRQoL) among patients with type 2 diabetes treated with oral antihyperglycemic agents.Keywords
This publication has 21 references indexed in Scilit:
- Patient‐reported outcomes in a survey of patients treated with oral antihyperglycaemic medications: associations with hypoglycaemia and weight gainDiabetes, Obesity and Metabolism, 2009
- Hypoglycaemia in patients with type 2 diabetes treated with a combination of metformin and sulphonylurea therapy in FranceDiabetes, Obesity and Metabolism, 2008
- Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real‐Life Effectiveness and Care Patterns of Diabetes Management (RECAP‐DM) StudyDiabetes, Obesity and Metabolism, 2008
- Hypoglycaemia in Type 2 diabetesDiabetic Medicine, 2008
- A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient educationPatient Education and Counseling, 2007
- Multivariate models of health-related utility and the fear of hypoglycaemia in people with diabetesCurrent Medical Research and Opinion, 2006
- The economic and quality of life impact of hypoglycemiaThe European Journal of Health Economics, 2005
- Defining and Reporting Hypoglycemia in DiabetesDiabetes Care, 2005
- US Valuation of the EQ-5D Health StatesMedical Care, 2005
- Negotiating the Barrier of Hypoglycemia in DiabetesDiabetes Spectrum, 2002